1 week Xenon Q3 Loss Narrower Than Expected, Pipeline Development in FocusZacks

XENE reports a narrower-than-expected third-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

Pharmaceuticals

17 hours ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?Zacks X

17 hours ARS Pharmaceuticals: Demand Curve Is Key UnknownSeeking Alpha X

18 hours Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbookCNBC X

20 hours Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?Zacks X

2 days Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

2 days Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here’s What You Should KnowZacks X

2 days Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)Seeking Alpha X

2 days Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3Insider Monkey X

2 days How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%Zacks X

2 days After Golden Cross, Milestone Pharmaceuticals (MIST)’s Technical Outlook is BrightZacks X

2 days Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?Zacks X

2 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks X

2 days Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” InvestmentInsider Monkey X

2 days Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street InteractiveZacks X

2 days NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call TranscriptSeeking Alpha X

3 days Elite Pharmaceuticals’ Stock Up Despite Q2 Earnings DeclineZacks X

3 days Jazz Pharmaceuticals: High Uncertainty, Low RiskSeeking Alpha X

3 days Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here’s is How to TradeZacks X

3 days Here’s Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 WeeksZacks X

3 days ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis StudyZacks X

3 days What Makes Eton Pharmaceuticals (ETON) a Good Fit for ‘Trend Investing’Zacks X

3 days Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?Insider Monkey X

5 days Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call TranscriptSeeking Alpha X

6 days Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

6 days Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call TranscriptThe Motley Fool X

6 days Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call TranscriptSeeking Alpha X

6 days Inovio Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

7 days 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue EstimatesZacks X

7 days Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary GoalZacks X

7 days 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

7 days New Strong Buy Stocks for November 14thZacks X

7 days EyePoint Pharmaceuticals: Low Price And Good Data Create An OpportunitySeeking Alpha X

1 week Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week X4 Pharmaceuticals, Inc. (XFOR) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue EstimatesZacks X

1 week Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue EstimatesZacks X

1 week Jazz (JAZZ) Upgraded to Buy: Here’s WhyZacks X

1 week Acurx Pharmaceuticals, Inc. (ACXP) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week JAZZ or CTLT: Which Is the Better Value Stock Right Now?Zacks X

1 week Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025?Insider Monkey X

1 week Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?Zacks X

1 week Wall Street Analysts See a 175.07% Upside in EyePoint Pharmaceuticals (EYPT): Can the Stock Really Move This High?Zacks X

1 week Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityThe Motley Fool X

1 week Corvus Pharmaceuticals, Inc. (CRVS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Lexicon Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

1 week Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 week Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call TranscriptSeeking Alpha X